SOP Guide for Pharma

API Manufacturing: SOP for Stage-Wise Approval of API Manufacturing – V 2.0

API Manufacturing: SOP for Stage-Wise Approval of API Manufacturing – V 2.0

Standard Operating Procedure for Stage-Wise Approval of API Manufacturing

Department API Manufacturing
SOP No. SOP/API/112/2025
Supersedes SOP/API/112/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for obtaining stage-wise approvals during the manufacturing of Active Pharmaceutical Ingredients (APIs), ensuring product quality, process consistency, and regulatory compliance at each critical process step.

2. Scope

This SOP applies to all manufacturing batches of APIs produced at the facility and covers approval checkpoints including raw material charging, reaction monitoring, filtration, drying, milling, blending, and final product release stages.

3. Responsibilities

  • Production Chemist: Notify QA at each critical manufacturing stage, provide necessary records, and await approval before proceeding.
  • QA Officer: Review IPC results, perform visual inspections, verify logbook entries, and grant written stage-wise clearance.
  • QC Analyst: Perform and release IPC test results required for each stage approval.

4. Accountability

The Production Head is accountable for implementing stage-wise controls. The QA Head is responsible for verifying process compliance before approving any manufacturing progression.

5. Procedure

5.1 Identified Manufacturing Stages for Approval

  1. Pre-Reaction: Raw material verification and charging
  2. Reaction Completion: pH, temperature, TLC results
  3. Post-Reaction Work-up: Phase separation confirmation
  4. Filtration: Filtrate clarity and wet cake inspection
  5. Drying: Moisture content (LOD)
  6. Milling and Sieving: Particle size distribution check
  7. Final Blending: Uniformity and identification

5.2 Stage-Wise Approval Process

  1. At each critical stage, Production shall inform QA in writing using the Stage Clearance Request Form (Annexure-1).
  2. QA shall:
    • Verify compliance with BMR entries
    • Review IPC results from QC
    • Check equipment cleanliness and line clearance
    • Confirm environmental conditions (if applicable)
  3. Once verified, QA shall record the decision in the Stage Approval Log (Annexure-2) and sign off the BMR page.
  4. Only after written clearance, the next step in manufacturing shall be initiated.

5.3 Documentation

  1. Each stage approval must include:
    • Stage description
    • Date and Time
    • Batch No.
    • Verification criteria
    • Signature of QA reviewer
  2. In case of hold or rejection at any stage, deviation must be recorded, and batch must not proceed until resolution.

5.4 Re-Approval (If Required)

  1. If a process deviation or batch hold is resolved:
    • QA shall reassess the stage parameters, IPC, and process justification.
    • Once acceptable, re-approval will be documented with revised date and remarks.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • IPC: In-Process Control

7. Documents

  1. Stage Clearance Request Form (Annexure-1)
  2. Stage Approval Logbook (Annexure-2)
  3. Batch Manufacturing Record (BMR)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • WHO TRS 986 – GMP Guidelines
  • 21 CFR Part 211 – US FDA cGMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stage Clearance Request Form

Stage Batch No. Date & Time Requested By QA Approval Remarks
Filtration API-20250413 13/04/2025 – 11:30 Ravi Kumar Approved

Annexure-2: Stage Approval Logbook

Date Stage Batch No. QA Review Done Remarks Signature
13/04/2025 Drying API-20250413 Yes LOD within range

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Compliance Requirement QA Head
13/04/2025 2.0 Added re-approval clause and annexures for traceability Audit Recommendation QA Head
Exit mobile version